The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1
about
The transcription factor p53: not a repressor, solely an activatorThe Ccr4-NOT deadenylase subunits CNOT7 and CNOT8 have overlapping roles and modulate cell proliferationThe transcriptional coregulator RIP140 represses E2F1 activity and discriminates breast cancer subtypesRole of DNA methylation in renal cell carcinomaFunction and Regulation of MicroRNAs and Their Potential as Biomarkers in Paediatric Liver DiseaseInfluence of cell cycle on responses of MCF-7 cells to benzo[a]pyreneThe suppressing effects of BTG3 expression on aggressive behaviors and phenotypes of colorectal cancer: An in vitro and vivo study.MicroRNA-142-5p promotes cell growth and migration in renal cell carcinoma by targeting BTG3Epstein-Barr virus BGLF4 kinase retards cellular S-phase progression and induces chromosomal abnormality.The suppressive role and aberrent promoter methylation of BTG3 in the progression of hepatocellular carcinomaRegulation of cellular miRNA expression by human papillomaviruses.The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy.Candidate tumor suppressor B-cell translocation gene 3 impedes neoplastic progression by suppression of AKT.ASBEL, an ANA/BTG3 antisense transcript required for tumorigenicity of ovarian carcinoma.Candidate tumor suppressor BTG3 maintains genomic stability by promoting Lys63-linked ubiquitination and activation of the checkpoint kinase CHK1Decreased Dicer expression elicits DNA damage and up-regulation of MICA and MICB.p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation.Distinct mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine resistance revealed by transcriptome mapping in mouse striatum.The dark side of a tumor suppressor: anti-apoptotic p53.BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.TTK/hMps1 mediates the p53-dependent postmitotic checkpoint by phosphorylating p53 at Thr18.Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma.Temporal profiling of rat transcriptomes in retinol-replenished vitamin A-deficient testis.BTG/TOB factors impact deadenylases.Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancerHedgehog inhibitor sonidegib potentiates 177Lu-octreotate therapy of GOT1 human small intestine neuroendocrine tumors in nude miceThe Paradox of p53: What, How, and Why?Inhibition of DNA damage-induced apoptosis through Cdc7-mediated stabilization of Tob.The interplay between transcription and mRNA degradation in Saccharomyces cerevisiaeLoss of the candidate tumor suppressor BTG3 triggers acute cellular senescence via the ERK-JMJD3-p16(INK4a) signaling axis.The expression of p53-regulated genes in human cultured lymphoblastoid TSCE5 and WTK1 cell lines during spaceflight.Circulating MicroRNAs in Plasma of Hepatitis B e Antigen Positive Children Reveal Liver-Specific Target Genes.Pathogenetic and Prognostic Significance of Inactivation of RASSF Proteins in Human Hepatocellular Carcinoma.The function of BTG3 in colorectal cancer cells and its possible signaling pathway.BTG3 Overexpression Suppresses the Proliferation and Invasion in Epithelial Ovarian Cancer Cell by Regulating AKT/GSK3β/β-Catenin Signaling.BTG3 upregulation induces cell apoptosis and suppresses invasion in esophageal adenocarcinoma.Deubiquitinating enzyme USP3 controls CHK1 chromatin association and activation.
P2860
Q24273295-3BB04B44-FE93-4415-99DE-C23AA89DE0FEQ24314993-51DFF3EB-9D7B-4F17-8A70-7963AB608BA7Q24617123-A6E16824-ADC3-4CC3-8E67-982A69A047C9Q26801268-65B396E4-122B-4147-9157-2D9986754657Q28073703-74AC193A-BB3B-40C4-9799-A5C21D172129Q28390752-01111DB7-4030-4985-A868-1C473498E2C0Q33566932-0CEA2CBF-7BEB-42A7-861E-8FAB99852D0DQ33733228-78EB02C9-ECB8-4A99-A0BB-F72BD95339EDQ34328083-1F12A60B-2981-477D-A28F-C3028AB2A65AQ35023159-BA3657A4-3C91-4507-AF72-E78B03D8DEDAQ35219098-D1B46A31-2983-42B3-96BE-954F5BCCD323Q36260657-BF9A89A8-21A2-4F2E-8CD0-6641B40A6011Q36347094-8C076C1C-CCBC-4149-8B14-228EFEDEF8CCQ36619041-92F37743-1102-4FAA-9287-3E522F34CCD2Q36762557-A5A21073-DCD3-4EE0-A91F-AE9B728C268FQ36790513-3047113E-4E71-4DB4-962A-BD79F6330A80Q37010494-657EFE0E-8C72-44CE-AE84-E39424E09AE9Q37076753-FC1AC8FF-CB9F-4EC9-8D2B-7113F453420EQ37115437-CF263334-3A90-4A70-B14C-80A50AC2819EQ37148045-79CBF41B-4D4C-4E64-9BD5-C8CA6225488EQ37192006-2263BA48-A544-49E9-9DFF-A402AD277E78Q37203783-A88BBEF5-7FEB-4AF7-8247-BE05DA52575EQ37409482-2D07ED44-9ACF-44E7-BD7F-39081DB79CD9Q37455743-F5D94213-A52A-47EF-AB04-489EBF0D0147Q38272302-BB27BC5B-FE74-47B7-A3AD-FD09D0FD0E4FQ38430202-CCB7E476-7DE3-4CDF-94AE-AAAAA5D47503Q38896065-56640F4E-49FF-49F9-8F28-0A17D2C4D533Q39259207-E3CEE04D-2447-4C15-9796-E7DAAAD2657AQ39434281-0CCE60D8-7330-48DA-86C0-E3F720DADC7BQ39454265-6931D760-FB49-4B40-99AF-7ECF86A6754FQ39673506-DF48FB8E-889F-4D53-8950-027EC6FEB03EQ41549935-123DDA77-144D-4442-B3E5-36BF964B46B1Q42040454-A9EF3F45-2F9F-4479-91E4-37E644682441Q47261925-89835E06-0394-4B76-95CA-8BDAFEB60137Q47864518-411B4B1A-DDF0-4272-BAD9-673F36D7BD3EQ52965377-33B39DE2-DA44-472D-83B7-8BA7589A4427Q53824680-EC496B97-97DF-4272-975B-D31C9FAF4B1E
P2860
The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1
@ast
The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1
@en
The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1
@en-gb
The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1
@nl
type
label
The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1
@ast
The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1
@en
The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1
@en-gb
The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1
@nl
prefLabel
The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1
@ast
The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1
@en
The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1
@en-gb
The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1
@nl
P2093
P2860
P356
P1433
P1476
The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1
@en
P2093
Fu-Fei Hsu
Pei-Han Chung
Sheau-Yann Shieh
Te-Ping Sun
Wen-Ying Chang
Yi-Hung Ou
P2860
P304
P356
10.1038/SJ.EMBOJ.7601825
P407
P577
2007-09-05T00:00:00Z